Nasdaq
$24.10▲ 2.10%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.28BShares out 94.6M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
25- 9.30After-hours26.10.01 05:068-KKey event#●●●
Fortrea Holdings Inc.
Fortrea Holdings has appointed Carrie Russell as Chief Accounting Officer, effective October 5, 2026. Her compensation package includes an annual base salary of $340,000, a 40% annual incentive bonus target, and eligibility for long-term incentive awards in the form of performance and restricted stock units.…more
$24.10+2.10%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.14After-hours26.09.15 05:224Ownership
Fortrea Holdings Inc.
Insider Jason Fredrick Knoblauch of Fortrea Holdings Inc. filed a Form 4 on September 14, 2026, reporting changes in beneficial ownership as of September 10, 2026. This filing is a routine disclosure of executive stock transactions and does not contain any material financial updates or significant corporate events.…more
$24.10+2.10%vs prev closeView filingShare - 9.11After-hours26.09.12 05:12144/AOther
Fortrea Holdings Inc.
Jill G. Mcconnell, an executive at Fortrea Holdings Inc., has filed a Form 144/A regarding the proposed sale of company securities. This filing discloses the insider's plan to sell a portion of their holdings.…more
$24.10+2.10%vs prev closeView filingShare
24 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 1d agoRegular26.10.24 01:58#●●●#●●●
Fortrea Partners with Omico to Advance Biomarker-Led Oncology Research
Fortrea has entered a strategic partnership with Omico to accelerate precision oncology research in Australia by optimizing patient recruitment and clinical trial matching. This collaboration is a strategic initiative without disclosed financial terms, maintaining a neutral outlook.…more
$24.10+2.10%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 2d agoAfter-hours26.10.23 05:05
●●●●●●●● ●●●●● ●●●●●●
Fortrea has entered a collaboration with Australia's Omico to accelerate biomarker-driven oncology clinical trials. The partnership aims to improve patient recruitment and trial planning by leveraging Omico's precision oncology network.…more
$24.10+2.10%vs prev close - 4d agoRegular26.10.21 03:42
●●●●●●●● ●●●●● ●●●●●●
Fortrea has completed the acquisition of Worldwide Clinical Trials' early phase services division for approximately $45 million in cash. While this move enhances the company's clinical trial and bioanalytical capabilities, the immediate financial impact remains to be seen.…more
$24.10+2.10%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report